Reviewed for Medical Accuracy by the Longevity Clinical Review Team
GLP-1 for Metabolic Health
Take control of your metabolic health with a low-dose, physician-supervised semaglutide or tirzepatide protocol.
Get my planTake control of your metabolic health with a low-dose, physician-supervised semaglutide or tirzepatide protocol.
Answer a few questions, get a provider-reviewed recommendation, and order in about two minutes. One flat monthly price whatever your dose, and the longer you commit, the less you pay. Pause or cancel at the end of any term.
Semaglutide
$169/mo on the 12-month plan
Single-pathway (GLP-1). Proven, well tolerated, the lower-cost way to start. One flat price at any dose.
Tirzepatide
$259/mo on the 12-month plan
Dual-action (GLP-1 + GIP). The strongest appetite control available and our usual recommendation. One flat price at any dose.
Compounded semaglutide and tirzepatide are prescription medications dispensed by a licensed US pharmacy only after a Longevity Center provider reviews your health history and writes a prescription. If you are not approved, your payment is refunded in full. Provider review, dose adjustments and messaging with your care team are included; labs and in-person visits are optional add-ons or part of a membership. Compounded medications are not FDA-approved. Individual results vary. Pricing is subject to change.
Every membership starts with your consultation, includes quarterly bloodwork, and gives you a provider who adjusts your protocol as your results change. Medication is the only thing billed separately.
From $245per month
Core, our most popular membership, is $395 a month (about $13 a day). 6-month minimum.
Book a free discovery callYour care team
The Longevity Center is a medical practice, not an app. A licensed provider reviews your history before anything is prescribed, sets your dose, and is the person who answers when you message us.
Nurse Practitioner
Board-certified women's health nurse practitioner who sees patients in Englewood and Lakewood. Kristen manages dosing, check-ins and the day-to-day questions that come with starting a new protocol.
Reviewed for Medical Accuracy by the Longevity Clinical Review Team
GLP-1 for Metabolic Health
While weight loss programs use GLP-1 at higher doses to suppress appetite, microdosing keeps the dose deliberately low. The target effect is steadiness. Appetite and post-meal blood sugar swings tend to feel steadier through the day. The mechanism: GLP-1 receptor agonism supports glucose-dependent insulin secretion when blood sugar is high,1 and slows how quickly food leaves the stomach.2
Low-dose use of GLP-1 medications for metabolic health is an off-label use. GLP-1 medications are FDA-approved for other uses; your physician determines whether an off-label protocol is appropriate for you.
While weight loss programs use GLP-1 at higher doses to suppress appetite, microdosing keeps the dose deliberately low. The target effect is steadiness. Appetite and post-meal blood sugar swings tend to feel steadier through the day. The mechanism: GLP-1 receptor agonism supports glucose-dependent insulin secretion when blood sugar is high,1 and slows how quickly food leaves the stomach.2
Tirzepatide works on two metabolic pathways (GLP-1 and GIP); semaglutide works on one and costs less. Your physician confirms the right fit at your assessment.
Compounded medications are not FDA-approved for safety, efficacy, or quality. Compounded medications are prepared by licensed 503A/503B pharmacies using pharmaceutical-grade active ingredients. They are not FDA-approved finished drug products. Longevity protocols require a physician prescription.
Well established
The glucose, insulin, and appetite-signaling mechanisms above are supported by consistent physiology research going back over a decade.
STILL emerging
Some research points to effects on inflammation and cardiometabolic markers like blood pressure and lipids. The strongest data so far comes from full-dose trials in people with obesity or existing heart disease.
Metabolism changes with age. Blood sugar creeps up, energy dips after meals, midsection fat holds on. This protocol is for people seeing those signals.
Two steps to qualify. A short intake asks your goal, then shows your customized protocol eligibility..
Some medical histories rule this out: medullary thyroid cancer or MEN 2 (personal or family), past pancreatitis, or pregnancy. Once you enroll, a physician reviews your history.
Assessment
Short intake on your goals and health history.
Physician review
A physician reviews your history and goals to build your plan.
Pharmacy fulfillment
Compounded and shipped from a licensed U.S. pharmacy.
Ongoing check-ins
Your clinician checks in at day 45 to make sure your first prescription is going smoothly.
Safety
The most common side effects across GLP-1 medications are digestive, nausea and changes in appetite or digestion, most noticeable when starting or changing a dose.3 Rare but serious risks include pancreatitis and gallbladder problems.
Contraindications and precautions: a personal or family history of medullary thyroid cancer or MEN 2 rules this out. A history of pancreatitis and pregnancy require physician review before starting.
Boxed warning: risk of thyroid C-cell tumors (MTC/MEN2). Read more ↓
Answer a few questions, pick your plan, and a licensed New Jersey provider reviews your answers within one business day. You are only charged if you are prescribed.
Get my planPrefer to talk first? Book a free callIt's a physician-supervised, low-dose GLP-1 protocol aimed at supporting metabolic health, glucose regulation, insulin sensitivity, and how you feel day to day, rather than weight loss. Longevity offers low-dose semaglutide (GLP-1 receptor agonist) and low-dose tirzepatide (dual GLP-1/GIP receptor agonist). 'Microdose' is a popular term, not an official clinical category; your physician sets your dose based on your goals and how you respond. This is an off-label use, prescribed at your physician's discretion.
This is not a weight-loss protocol. Some members do see modest early changes, but weight loss is not the goal and not something this protocol is dosed to deliver. If your goal is losing weight, or keeping it off after a GLP-1 program, the standard Longevity program is the right fit. We'll route you there.
The underlying medication has strong evidence for blood sugar and appetite regulation, mostly in people with diabetes or obesity. For general metabolic optimization in healthy people, the research is still early.
Most members start with tirzepatide. It works on two metabolic pathways (GLP-1 and GIP), where semaglutide works on one, that broader mechanism is why it's usually our recommended starting point. Semaglutide is fully supported and is the lower-cost option if that's the deciding factor.
Microdosing uses the same medications as standard GLP-1 programs, so the same class of risks applies regardless of dose. The common side effects are digestive (nausea, and changes in appetite or digestion), usually strongest when you start or change a dose. There are also rare but serious risks, including pancreatitis and gallbladder problems. Your physician reviews your history for these before you start and monitors you throughout.
No. GLP-1 medications are FDA-approved for specific uses like type 2 diabetes and chronic weight management. Using them at a low dose for general metabolic health is an off-label use, and compounded medications are not FDA-approved for safety, efficacy, or quality. That's why this runs under physician supervision with individualized dosing.
Once you enroll, a physician reviews your medical history and current treatments before anything ships. They're checking a short list of specific conditions, not a BMI or weight bar. If that review finds you're not a fit, ineligibility qualifies for a full refund.
Reviewed for Medical Accuracy by the Longevity Clinical Review Team
Trusted by men and women across New Jersey at our Englewood and Lakewood Centers.
Reviewed for Medical Accuracy by the Longevity Clinical Review Team
Boxed warning: risk of thyroid C-cell tumors (MTC/MEN2).
Semaglutide and tirzepatide carry a boxed warning for risk of thyroid C-cell tumors. Do not use with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Compounded medications are prepared by licensed 503A/503B pharmacies using pharmaceutical-grade active ingredients. They are not FDA-approved finished drug products. Longevity protocols require a physician prescription.
